- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/74 - Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
Patent holdings for IPC class C07D 213/74
Total number of patents in this class: 1571
10-year publication summary
|
96
|
123
|
98
|
80
|
69
|
70
|
83
|
71
|
69
|
60
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Centre National de La Recherche Scientifique | 10706 |
32 |
| Novartis AG | 10612 |
31 |
| Bristol-myers Squibb Company | 4826 |
28 |
| Institut Curie | 608 |
26 |
| Boehringer Ingelheim International GmbH | 4636 |
23 |
| Universite de Montpellier | 1021 |
21 |
| Abivax | 122 |
19 |
| F. Hoffmann-La Roche AG | 7937 |
18 |
| Samsung Display Co., Ltd. | 36317 |
16 |
| Takeda Pharmaceutical Company Limited | 2721 |
16 |
| Celgene Quanticel Research, Inc. | 162 |
14 |
| The Regents of the University of California | 20303 |
13 |
| Abbvie Inc. | 1817 |
13 |
| Oxular Acquisitions Limited | 21 |
13 |
| Genentech, Inc. | 4016 |
12 |
| Janssen Pharmaceutica N.V. | 3358 |
11 |
| The Johns Hopkins University | 5756 |
11 |
| Nippon Soda Co., Ltd. | 892 |
11 |
| Astellas Pharma Inc. | 1057 |
10 |
| Merck Patent GmbH | 5752 |
9 |
| Other owners | 1224 |